World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 77 1783 1628 879 791 360 61499

Alan J. Korman publications per year

The chart shows the history of publications by Alan J. Korman between 1980 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Alan J. Korman published across 47 years, from 1980 to 2026, averaging 10.5 papers a year. Output peaked at 215 publications in 2023. 4 of the 493 publications appeared in the last two years.

No. of publications
50 100 150 200
Bar chart. Horizontal axis: year, 1980 to 2026. Vertical axis: number of publications, 0 to 215. Peak 215 publications in 2023. 1980: 2 publications 1981: 0 publications 1982: 4 publications 1983: 3 publications 1984: 3 publications 1985: 1 publication 1986: 0 publications 1987: 4 publications 1988: 1 publication 1989: 1 publication 1990: 0 publications 1991: 0 publications 1992: 1 publication 1993: 1 publication 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 0 publications 1999: 0 publications 2000: 10 publications 2001: 1 publication 2002: 0 publications 2003: 5 publications 2004: 1 publication 2005: 1 publication 2006: 13 publications 2007: 15 publications 2008: 5 publications 2009: 10 publications 2010: 6 publications 2011: 5 publications 2012: 10 publications 2013: 19 publications 2014: 4 publications 2015: 20 publications 2016: 25 publications 2017: 20 publications 2018: 19 publications 2019: 19 publications 2020: 21 publications 2021: 14 publications 2022: 6 publications 2023: 215 publications 2024: 4 publications 2025: 3 publications 2026: 1 publication
1980 2026

493 publications in total across all disciplines

View publications per year as a table
Alan J. Korman: publications per year, 1980 to 2026
Year Publications
1980 2
1981 0
1982 4
1983 3
1984 3
1985 1
1986 0
1987 4
1988 1
1989 1
1990 0
1991 0
1992 1
1993 1
1994 0
1995 0
1996 0
1997 0
1998 0
1999 0
2000 10
2001 1
2002 0
2003 5
2004 1
2005 1
2006 13
2007 15
2008 5
2009 10
2010 6
2011 5
2012 10
2013 19
2014 4
2015 20
2016 25
2017 20
2018 19
2019 19
2020 21
2021 14
2022 6
2023 215
2024 4
2025 3
2026 1
Total 493
Download as CSV

Alan J. Korman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Alan J. Korman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 352–361 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 360 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69 360
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Alan J. Korman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Alan J. Korman sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 76–77 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163 77
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Alan J. Korman is affiliated with VIR Biotechnology in the United States, with a research focus primarily in the fields of Immunology and Microbiology and Medicine. Their work spans various subfields including Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Biomedical Engineering.

The scientist's research concentrates on topics related to cancer immunotherapy and biomarkers, immune cell function and interaction, immunotherapy and immune responses, as well as T-cell and B-cell immunology. Additional topics include CAR-T cell therapy research, immune cells in cancer, and monoclonal and polyclonal antibodies research.

Frequent publication venues for their work include Cancer Research, Nature Reviews Drug Discovery, Clinical Cancer Research, Journal of Clinical Investigation, and Nature Communications.

  • Cancer Research
  • Nature Reviews Drug Discovery
  • Clinical Cancer Research
  • Journal of Clinical Investigation
  • Nature Communications

Alan J. Korman has co-authored multiple works with researchers such as Mark Selby, Charles G. Drake, Pavel Strop, Joë-Marc Chauvin, and Mignane Ka.

  • Mark Selby
  • Charles G. Drake
  • Pavel Strop
  • Joë-Marc Chauvin
  • Mignane Ka

Some of the notable recent publications include:

  • The foundations of immune checkpoint blockade and the ipilimumab approval decennial, 2021, Nature Reviews Drug Discovery
  • Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates, 2023, Journal of Clinical Oncology
  • IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma, 2020, Clinical Cancer Research
  • A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target, 2020, Journal of Clinical Investigation
  • Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models, 2021, Cancer Research

Best Publications

  • Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

    Suzanne L. Topalian;F. Stephen Hodi;Julie R. Brahmer;Scott N. Gettinger

  • Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

    Julie R. Brahmer;Scott S. Tykodi;Scott S. Tykodi;Laura Q.M. Chow;Wen Jen Hwu

  • Nivolumab plus Ipilimumab in Advanced Melanoma

    Jedd D. Wolchok;Harriet Kluger;Margaret K. Callahan;Michael A. Postow

  • Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

    Julie R. Brahmer;Charles G. Drake;Ira Wollner;John D. Powderly

  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

  • Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

    Seng Ryong Woo;Meghan E Turnis;Monica V Goldberg;Jaishree Bankoti

  • 1 -1 HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1PD-L1

    Korman Alan J;Selby Mark J;Wang Changyu;Srinivasan Mohan

  • Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

    F. Stephen Hodi;Martin C. Mihm;Robert J. Soiffer;Frank G. Haluska

  • Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.

    Mark J. Selby;John J. Engelhardt;Michael Quigley;Karla A. Henning

  • Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

    Karl S. Peggs;Sergio A. Quezada;Cynthia A. Chambers;Alan J. Korman

  • TIGIT and PD-1 impair tumor antigen–specific CD8 + T cells in melanoma patients

    Joe-Marc Chauvin;Ornella Pagliano;Julien Fourcade;Zhaojun Sun

  • The class II molecules of the human and murine major histocompatibility complex.

    James F. Kaufman;Charles Auffray;Alan J. Korman;Deborah A. Shackelford

  • Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

    F. Stephen Hodi;Marcus Butler;Darryl A. Oble;Michael V. Seiden;Michael V. Seiden

  • Checkpoint blockade in cancer immunotherapy

    Alan J. Korman;Karl S. Peggs;James P. Allison

  • Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts

    Tucker Collins;Alan J. Korman;Claire T. Wake;Jeremy M. Boss

  • Evolving synergistic combinations of targeted immunotherapies to combat cancer.

    Ignacio Melero;David M. Berman;M. Angela Aznar;Alan J. Korman

  • In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.

    Changyu Wang;Kent B. Thudium;Minhua Han;Xi-Tao Wang

  • Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.

    Karl S Peggs;Sergio A Quezada;Alan J Korman;James P Allison

  • The foundations of immune checkpoint blockade and the ipilimumab approval decennial

    Unknown

  • FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

    Rony Dahan;Emanuela Sega;John Engelhardt;Mark Selby

  • Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

    Jedd D. Wolchok;F. Stephen Hodi;Jeffrey S. Weber;James P. Allison

Frequent Co-Authors

Charles G. Drake
Charles G. Drake Columbia University
James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Paul M. Harari
Paul M. Harari University of Wisconsin–Madison
Suzanne L. Topalian
Suzanne L. Topalian Johns Hopkins University
Michael A. Postow
Michael A. Postow Memorial Sloan Kettering Cancer Center
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Jon M. Wigginton
Jon M. Wigginton Bristol-Myers Squibb (Germany)
Jacquelyn A. Hank
Jacquelyn A. Hank University of Wisconsin–Madison
Paul M. Sondel
Paul M. Sondel University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career options. Many students also pursue nursing paths that complement immunology knowledge, such as accelerated nursing programs. Finding accelerated nursing programs near me offers a faster route into clinical roles while building a strong foundation in patient care.

Entry-level roles like Licensed Practical Nurse (LPN) positions provide practical experience in healthcare settings. Students looking for flexible options may explore lpn programs with easiest admission requirements, which help streamline the application process and get you started quickly.

Advancing to specialized practice, nurse practitioner degrees enhance clinical expertise. Those seeking a more accessible route can consider the easiest nurse practitioner program options available online, designed to balance quality education with manageable admission standards.

For professionals focused on mental health, psychiatric-mental health nurse practitioner (PMHNP) programs offer rewarding career paths. Choosing from the best pmhnp programs online ensures excellent clinical placement support and practical experience, which are critical for success in healthcare roles tied to immunologic and psychological well-being.

Best Scientists Citing Alan J. Korman

Trending Scientists

Recently Published Articles